[go: up one dir, main page]

AU5658094A - Use of potassium channel activators for the manufacture of a medicament for the treatment of pain - Google Patents

Use of potassium channel activators for the manufacture of a medicament for the treatment of pain

Info

Publication number
AU5658094A
AU5658094A AU56580/94A AU5658094A AU5658094A AU 5658094 A AU5658094 A AU 5658094A AU 56580/94 A AU56580/94 A AU 56580/94A AU 5658094 A AU5658094 A AU 5658094A AU 5658094 A AU5658094 A AU 5658094A
Authority
AU
Australia
Prior art keywords
pain
medicament
manufacture
treatment
potassium channel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU56580/94A
Inventor
Jonathan Robert Sanders Arch
Geoffrey Douglas Clarke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
GlaxoSmithKline SpA
Original Assignee
SMITHKLINE BEECHAM FARMA
SmithKline Beecham Ltd
Smithkline Beecham Farmaceutici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SMITHKLINE BEECHAM FARMA, SmithKline Beecham Ltd, Smithkline Beecham Farmaceutici SpA filed Critical SMITHKLINE BEECHAM FARMA
Publication of AU5658094A publication Critical patent/AU5658094A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU56580/94A 1992-12-17 1993-12-14 Use of potassium channel activators for the manufacture of a medicament for the treatment of pain Abandoned AU5658094A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929226302A GB9226302D0 (en) 1992-12-17 1992-12-17 Pharmaceuticals
GB9226302 1992-12-17
PCT/GB1993/002548 WO1994013272A1 (en) 1992-12-17 1993-12-14 Use of potassium channel activators for the manufacture of a medicament for the treatment of pain

Publications (1)

Publication Number Publication Date
AU5658094A true AU5658094A (en) 1994-07-04

Family

ID=10726751

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56580/94A Abandoned AU5658094A (en) 1992-12-17 1993-12-14 Use of potassium channel activators for the manufacture of a medicament for the treatment of pain

Country Status (3)

Country Link
AU (1) AU5658094A (en)
GB (1) GB9226302D0 (en)
WO (1) WO1994013272A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP9701865A3 (en) * 1997-11-06 2000-01-28 Egyt Gyogyszervegyeszeti Gyar Pyrano[3,2-c]pyridine derivatives and pharmaceutical compositons containing them, process for the preparation and use thereof
GB9909792D0 (en) * 1998-12-04 1999-06-23 Cambridge Bioclinical Limited Potassium channel activators and their use
DK2464645T3 (en) 2009-07-27 2017-10-23 Gilead Sciences Inc CONDENSED, HETEROCYCLIC COMPOUNDS AS IRON CHANNEL MODULATORS
US8703759B2 (en) 2010-07-02 2014-04-22 Gilead Sciences, Inc. Fused heterocyclic compounds as ion channel modulators
PL2707361T3 (en) 2011-05-10 2018-01-31 Gilead Sciences Inc Fused heterocyclic compounds as sodium channel modulators
TWI622583B (en) 2011-07-01 2018-05-01 基利科學股份有限公司 Fused heterocyclic compound as ion channel regulator
NO3175985T3 (en) 2011-07-01 2018-04-28

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250547A (en) * 1991-08-29 1993-10-05 Syntex (U.S.A.) Inc. Benzopyran derivatives

Also Published As

Publication number Publication date
GB9226302D0 (en) 1993-02-10
WO1994013272A1 (en) 1994-06-23

Similar Documents

Publication Publication Date Title
AU667899B2 (en) Disposable diapers
HK1002907B (en) Disposable diaper
AU3525293A (en) Disposable diapers
AU3674093A (en) Disposable diapers
AU4465893A (en) Disposable diapers
AU3525393A (en) Disposable diapers
AU4139193A (en) Disposable diapers
AU6623894A (en) Therapeutic compounds
AU3888793A (en) Novel medicament
AU4452193A (en) Disposable diapers
AU7931194A (en) Apparatus for treatment of the oral cavity
HU9300536D0 (en) Compounds of medical effect
EP0575749A3 (en) Use of potassium-channel activators for the manufacture of a medicament for the treatment of gastrointertinal ulcers
EP0765663A3 (en) Use of dienogest for the manufacture of a medicament for the treatment of the skin by topical application
AU7269294A (en) Use of glucokinase inhibitors for the manufacture of a medicament for treating tumours
AU6092794A (en) Oxime-substituted therapeutic compounds
AU2807492A (en) Use of misoprostol for the treatment of allergy
AU2806692A (en) Medicament for the treatment of anxiety
AU1116895A (en) Use of theophylline for the manufacture of a medicament for the treatment of asthma
AU5658094A (en) Use of potassium channel activators for the manufacture of a medicament for the treatment of pain
EP0765661A3 (en) Use of docosahexaenoic acid for the manufacture of a medicament for the treatment of glumerulonephritis
AU2787495A (en) Use of copolymer-1 for the manufacture of a medicament for the treatment of optic neuritis
AU4879493A (en) Disposable diapers
AU5340594A (en) Skin treatment
AU4081393A (en) Medicaments for the treatment of anxiety